Literature DB >> 32335245

Parenchyma-sparing liver resections.

Guido Torzilli1, Lucas McCormack2, Timothy Pawlik3.   

Abstract

Modern liver surgeon must be equipped with excellent theoretical and clinical skills to perform a perfect liver resection. A particular and growing relevance is devoted to parenchyma sparing liver surgery (PSS). Indeed, reducing the sacrifice of functioning parenchyma is one of the keys of a successful surgery, once oncological issues are properly addressed. Intraoperative ultrasound together with oncological and anatomical new insights have enhanced the possibility to offer PSS even in advanced disease usually afforded with major resections or staged procedures or even considered unresectable. These complex hepatectomies are mainly performed with open surgery, while major or staged procedures could be faced with minimal access liver surgery (MALS): that is generating a potential conflict between open PSS and MALS major hepatectomies. An overall evaluation of oncological radicality, safety, salvageability, and quality of life suggest to prioritize PSS, which is always minimal invasive liver surgery in a hepatic-centered perspective, while MALS is not.
Copyright © 2020 IJS Publishing Group Ltd. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cholangiocarcinoma; Colorectal liver metastases; Hepatectomy; Hepatocellular carcinoma; Intraoperative ultrasound; Liver metastases; Liver tumors; Liver tunnel; Mini-meso-hepatectomy; Minimal access liver surgery; Minimal invasive liver surgery; Parenchyma sparing surgery; R1 vascular; Upper transversal hepatectomy

Year:  2020        PMID: 32335245     DOI: 10.1016/j.ijsu.2020.04.047

Source DB:  PubMed          Journal:  Int J Surg        ISSN: 1743-9159            Impact factor:   6.071


  8 in total

1.  Parenchyma-sparing vessel-guided major hepatectomies: Nonsense or new paradigm?

Authors:  Guido Torzilli
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2021-06-30

2.  ASO Author Reflections: Thoraco-Abdominal Approach with Phrenotomy for Large Liver Tumor in Close Contact with the Vena Cava and the Hepatocaval Confluence.

Authors:  F Crafa; S Vanella; E Coppola Bottazzi; A Noviello; A Miro; T Palma; I Apicella
Journal:  Ann Surg Oncol       Date:  2021-09-01       Impact factor: 5.344

3.  Feasibility of Right Upper Transversal Hepatectomy in the Absence of an Inferior Right Hepatic Vein: New Insights regarding This Complex Procedure.

Authors:  Fabio Ferrari Makdissi; Jaime Arthur Pirola Kruger; Vagner Birk Jeismann; Paulo Herman
Journal:  Case Rep Surg       Date:  2021-03-06

4.  Partial hepatectomy for treatment of multiple liver abscess in a calf: a case report.

Authors:  Reiichiro Sato; Kazutaka Yamada; Taiki Yokoyama; Koki Tanimoto; Shoko Takeuchi; Natsumi Tatsuzawa; Shiho Nakui; Hiroyuki Satoh; Mahmoud Fadul; Adrian Steiner
Journal:  BMC Vet Res       Date:  2021-02-03       Impact factor: 2.741

5.  Left Anterior Sectorectomy: An Alternative to Left Hepatectomy for Tumors Invading the Distal Part of the Left Portal Vein.

Authors:  Mattia Garancini; Mauro Alessandro Scotti; Luca Gianotti; Cristina Ciulli; Francesca Carissimi; Fabio Uggeri; Luca Degrate; Marco Braga; Fabrizio Romano
Journal:  Diagnostics (Basel)       Date:  2022-02-21

6.  Placement of vein grafting in liver surgery at the time of the R1 vascular concept and the communicating veins.

Authors:  Guido Torzilli
Journal:  Hepatobiliary Surg Nutr       Date:  2022-08       Impact factor: 8.265

7.  The Impact of Postoperative Complications on Survival after Simultaneous Resection of Colorectal Cancer and Liver Metastases.

Authors:  Sorin Tiberiu Alexandrescu; Narcis Octavian Zarnescu; Andrei Sebastian Diaconescu; Dana Tomescu; Gabriela Droc; Doina Hrehoret; Vladislav Brasoveanu; Irinel Popescu
Journal:  Healthcare (Basel)       Date:  2022-08-19

8.  Liver transplantation and hepatobiliary surgery in 2020.

Authors:  Burcin Ekser; Karim J Halazun; Henrik Petrowsky; Deniz Balci
Journal:  Int J Surg       Date:  2020-07-19       Impact factor: 13.400

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.